95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.19%
Revenue growth under 50% of NEM's 7.75%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
9.00%
Gross profit growth under 50% of NEM's 28.62%. Michael Burry would be concerned about a severe competitive disadvantage.
6.22%
EBIT growth below 50% of NEM's 32.44%. Michael Burry would suspect deeper competitive or cost structure issues.
6.22%
Operating income growth under 50% of NEM's 32.44%. Michael Burry would be concerned about deeper cost or sales issues.
-25.44%
Negative net income growth while NEM stands at 401.76%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-25.00%
Negative EPS growth while NEM is at 428.57%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-25.00%
Negative diluted EPS growth while NEM is at 428.57%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.07%
Share change of 0.07% while NEM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.10%
Diluted share count expanding well above NEM's 0.17%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
6.73%
OCF growth under 50% of NEM's 79.64%. Michael Burry might suspect questionable revenue recognition or rising costs.
176.60%
FCF growth under 50% of NEM's 902.70%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
58.74%
10Y revenue/share CAGR above 1.5x NEM's 5.71%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
55.15%
5Y revenue/share CAGR above 1.5x NEM's 26.90%. David Dodd would look for consistent product or market expansions fueling outperformance.
-10.17%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
79.88%
10Y OCF/share CAGR 1.25-1.5x NEM's 60.88%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
110.42%
5Y OCF/share CAGR at 50-75% of NEM's 209.74%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
7.26%
Positive 3Y OCF/share CAGR while NEM is negative. John Neff might see a big short-term edge in operational efficiency.
51.96%
Below 50% of NEM's 105.09%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
196.44%
Below 50% of NEM's 2366.78%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-26.91%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
61.34%
10Y equity/share CAGR above 1.5x NEM's 24.28%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
37.69%
5Y equity/share CAGR above 1.5x NEM's 0.85%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
19.58%
Positive short-term equity growth while NEM is negative. John Neff sees a strong advantage in near-term net worth buildup.
144.99%
Below 50% of NEM's 942.29%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
115.34%
Stable or rising mid-term dividends while NEM is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
33.37%
Our short-term dividend growth is positive while NEM cut theirs. John Neff views it as a comparative advantage in shareholder returns.
80.90%
AR growth well above NEM's 22.12%. Michael Burry fears inflated revenue or higher default risk in the near future.
-8195400.00%
Inventory is declining while NEM stands at 0.85%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.97%
Asset growth above 1.5x NEM's 0.62%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.18%
50-75% of NEM's 1.68%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-3.35%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
42.05%
We expand SG&A while NEM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.